Asuka Kaizaki-Mitsumoto, Naoki Noguchi, Saki Yamaguchi, Yuki Odanaka, Satoko Matsubayashi, Hiroki Kumamoto, Kiyoshi Fukuhara, Masahiko Funada, Kiyoshi Wada, Satoshi Numazawa: Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE, newly identified in ingredients of drug products before they were sold on the drug market. Forensic Toxicology, November 2015. doi:10.1007/s11419-015-0293-6Artikkelin verkkoversio.
Asuka Kaizaki-Mitsumoto, Naoki Noguchi, Saki Yamaguchi, Yuki Odanaka, Satoko Matsubayashi, Hiroki Kumamoto, Kiyoshi Fukuhara, Masahiko Funada, Kiyoshi Wada, Satoshi Numazawa: Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE, newly identified in ingredients of drug products before they were sold on the drug market. Forensic Toxicology, November 2015. doi:10.1007/s11419-015-0293-6Artikkelin verkkoversio.